Skip to main content

Table 5 Events after 1st treatment (based on dose received)

From: Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report

 

AE

# Occurrences

Event Rate %

50 mg dose

N = 3

Nausea

1

33.3

 

Vomiting

1

33.3

 

Hypertension

1

33.3

 

Liver Dysfunction

1

33.3

100 mg dose

N = 45

Nausea

2

4.4

 

Vomiting

1

2.2

 

Gastritis

1

2.2

 

Pain

1

2.2

 

Liver Dysfunction

1

2.2

150 mg dose

N = 1

Nausea

1

100

 

Vomiting

1

100

 

Anorexia

1

100

200 mg dose

N = 6

Liver dysfunction

1

16.7